{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:08:39Z","timestamp":1787162919926,"version":"build-2736575974"},"reference-count":135,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Numerous treatments are available for cancer, including chemotherapy, immunotherapy, radiation therapy, hormone therapy, biomarker testing, surgery, photodynamic therapy, etc. Photodynamic therapy (PDT) is an effective, non-invasive, novel, and clinically approved strategy to treat cancer. In PDT, three main agents are utilized, i.e., photosensitizer (PS) drug, oxygen, and light. At first, the photosensitizer is injected into blood circulation or applied topically, where it quickly becomes absorbed or accumulated at the tumor site passively or actively. Afterward, the tumor is irradiated with light which leads to the activation of the photosensitizing molecule. PS produces the reactive oxygen species (ROS), resulting in the death of the tumor cell. However, the effectiveness of PDT for tumor destruction is mainly dependent on the cellular uptake and water solubility of photosensitizer molecules. Therefore, the delivery of photosensitizer molecules to the tumor cell is essential in PDT against cancer. The non-specific distribution of photosensitizer results in unwanted side effects and unsuccessful therapeutic outcomes. Therefore, to improve PDT clinical outcomes, the current research is mostly focused on developing actively targeted photosensitizer molecules, which provide a high cellular uptake and high absorption capacity to the tumor site by overcoming the problem associated with conventional PDT. Therefore, this review aims to provide current knowledge on various types of actively and passively targeted organic and inorganic nanocarriers for different cancers.<\/jats:p>","DOI":"10.3390\/pharmaceutics15010109","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T02:52:21Z","timestamp":1672282341000},"page":"109","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Multifunctional Photoactive Nanomaterials for Photodynamic Therapy against Tumor: Recent Advancements and Perspectives"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9625-8396","authenticated-orcid":false,"given":"Rupesh","family":"Jain","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Pilani Campus, Pilani 333031, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shambo","family":"Mohanty","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Pilani Campus, Pilani 333031, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ila","family":"Sarode","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Pilani Campus, Pilani 333031, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1575-4206","authenticated-orcid":false,"given":"Swati","family":"Biswas","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Hyderabad Campus, Hyderabad 500078, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9706-9244","authenticated-orcid":false,"given":"Gautam","family":"Singhvi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Pilani Campus, Pilani 333031, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil Kumar","family":"Dubey","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Pilani Campus, Pilani 333031, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,28]]},"reference":[{"key":"ref_1","unstructured":"World Health Organisation (2022, July 24). Cancer\u2014Key Facts. Available online: http:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2174\/1389450117666160527142544","article-title":"Smart Drug-Delivery Systems for Cancer Nanotherapy","volume":"19","author":"Marchal","year":"2018","journal-title":"Curr. Drug Targets"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1021\/ab500084g","article-title":"Nanotherapy for Cancer: Targeting and Multifunctionality in the Future of Cancer Therapies","volume":"1","author":"Ediriwickrema","year":"2015","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.drudis.2021.12.005","article-title":"The Hedgehog pathway and its inhibitors: Emerging therapeutic approaches for basal cell carcinoma","volume":"27","author":"Jain","year":"2021","journal-title":"Drug Discov. Today"},{"key":"ref_5","unstructured":"(2021, July 24). Cancer Treatment\u2014Mayo Clinic. Available online: https:\/\/www.mayoclinic.org\/tests-procedures\/cancer-treatment\/about\/pac-20393344."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3322\/caac.20114","article-title":"Photodynamic therapy of cancer: An update","volume":"61","author":"Agostinis","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2012.07.026","article-title":"Biomodulatory approaches to photodynamic therapy for solid tumors","volume":"326","author":"Anand","year":"2012","journal-title":"Cancer Lett."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jnci\/90.12.889","article-title":"Photodynamic Therapy","volume":"90","author":"Dougherty","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Banerjee, S.M., El-Sheikh, S., Malhotra, A., Mosse, C.A., Parker, S., Williams, N.R., MacRobert, A.J., Hamoudi, R., Bown, S.G., and Keshtgar, M.R. (2020). Photodynamic Therapy in Primary Breast Cancer. J. Clin. Med., 9.","DOI":"10.3390\/jcm9020483"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrc1071","article-title":"Photodynamic therapy for cancer","volume":"3","author":"Dolmans","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1470-2045(00)00166-2","article-title":"Photodynamic therapy: A clinical reality in the treatment of cancer","volume":"1","author":"Hopper","year":"2000","journal-title":"Lancet Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.2174\/1381612826666200826140448","article-title":"Nanocarrier Based Topical Drug Delivery\u2014A Promising Strategy for Treatment of Skin Cancer","volume":"26","author":"Jain","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2155-9872.S1-e001","article-title":"Photodynamic Therapy as an Emerging Treatment Modality for Cancer and Non-Cancer Diseases","volume":"S1","author":"Hu","year":"2014","journal-title":"J. Anal. Bioanal. Tech."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Niculescu, A.-G., and Grumezescu, A. (2021). Photodynamic Therapy\u2014An Up-to-Date Review. Appl. Sci., 11.","DOI":"10.3390\/app11083626"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"100044","DOI":"10.1016\/j.phyplu.2021.100044","article-title":"Light-activated green drugs: How we can use them in photodynamic therapy and mass-produce them with biotechnological tools","volume":"1","author":"Foresto","year":"2021","journal-title":"Phytomed. Plus"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.biopha.2018.07.049","article-title":"Photodynamic therapy\u2014Mechanisms, photosensitizers and combinations","volume":"106","author":"Kwiatkowski","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1021\/jm040074b","article-title":"Current Clinical and Preclinical Photosensitizers for Use in Photodynamic Therapy","volume":"47","author":"Detty","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1142\/S1088424619300192","article-title":"Application of photodynamic therapy drugs for management of glioma","volume":"23","author":"Dubey","year":"2019","journal-title":"J. Porphyr. Phthalocyanines"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrc1894","article-title":"Photodynamic therapy and anti-tumour immunity","volume":"6","author":"Castano","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1572-1000(05)00007-4","article-title":"Mechanisms in photodynamic therapy: Part one\u2014Photosensitizers, photochemistry and cellular localization","volume":"1","author":"Castano","year":"2004","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1572-1000(05)00060-8","article-title":"Mechanisms in photodynamic therapy: Part three\u2014Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction","volume":"2","author":"Castano","year":"2005","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1572-1000(05)00030-X","article-title":"Mechanisms in photodynamic therapy: Part two\u2014Cellular signaling, cell metabolism and modes of cell death","volume":"2","author":"Castano","year":"2005","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jphotobiol.2009.04.001","article-title":"Photodynamic therapy (PDT): A short review on cellular mechanisms and cancer research applications for PDT","volume":"96","author":"Robertson","year":"2009","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00403-003-0424-5","article-title":"Activation of two caspase cascades, caspase 8\/3\/6 and caspase 9\/3\/6, during photodynamic therapy using a novel photosensitizer, ATX-S10(Na), in normal human keratinocytes","volume":"295","author":"Takahashi","year":"2003","journal-title":"Arch. Dermatol. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.18388\/abp.2005_3447","article-title":"Direct tumor damage mechanisms of photodynamic therapy","volume":"25","author":"Nowis","year":"2005","journal-title":"Acta Biochim. Pol."},{"key":"ref_26","unstructured":"(2021, December 14). Hypoxia Inducible Factor (HIF-1a and HIF-2a) Expression in Early Esophageal Cancer and Response to Photodynamic Therapy and Radiotherapy|Cancer Research|American Association for Cancer Research. Available online: https:\/\/aacrjournals.org\/cancerres\/article\/61\/5\/1830\/508681\/Hypoxia-Inducible-Factor-HIF-1a-and-HIF-2a."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.tibtech.2008.07.007","article-title":"Nanoparticles as vehicles for delivery of photodynamic therapy agents","volume":"26","author":"Bechet","year":"2008","journal-title":"Trends Biotechnol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1751-1097.1986.tb09501.x","article-title":"Direct detection of singlet oxygen sensitized by haematoporphyrin and related compounds","volume":"43","author":"Keene","year":"1986","journal-title":"Photochem. Photobiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"118823","DOI":"10.1016\/j.saa.2020.118823","article-title":"Fluorescence-based method for sensitive and rapid estimation of chlorin e6 in stealth liposomes for photodynamic therapy against cancer","volume":"244","author":"Jain","year":"2020","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"ref_30","first-page":"1271","article-title":"Porfimer sodium (Photofrin-II). Gan to Kagaku ryoho","volume":"22","author":"Tsukagoshi","year":"1995","journal-title":"Cancer Chemother."},{"key":"ref_31","unstructured":"(2022, August 22). Photodynamic Therapy with Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract\u2014Full Text View\u2014ClinicalTrials.Gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00453336."},{"key":"ref_32","unstructured":"(2022, August 23). Hpph|C39H48N4O4\u2014PubChem, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Hpph#section=Names-and-Identifiers."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3892\/ol.2013.1493","article-title":"Efficacy of 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a in photodynamic therapy of human esophageal squamous cancer cells","volume":"6","author":"Wu","year":"2013","journal-title":"Oncol. Lett."},{"key":"ref_34","unstructured":"(2022, August 23). AL(III) Phthalocyanine Chloride Tetrasulfonic Acid|C32H16AlClN8O12S4\u2014PubChem, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/AL_III_-Phthalocyanine-chloride-tetrasulfonic-acid."},{"key":"ref_35","unstructured":"(2022, August 23). Aluminum Phthalocyanine|C32H16AlN8+\u2014PubChem, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Aluminum-phthalocyanine."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"102158","DOI":"10.1016\/j.pdpdt.2020.102158","article-title":"Photodynamic therapy for prostate cancer\u2014A narrative review","volume":"33","author":"Osuchowski","year":"2020","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2176\/nmc.ra.2015-0296","article-title":"Photodynamic Therapy for Malignant Brain Tumors","volume":"56","author":"Akimoto","year":"2016","journal-title":"Neurol. Med.-Chir."},{"key":"ref_38","unstructured":"(2022, August 22). Aminolevulinic Acid Hydrochloride, Known as ALA HCl (Gleolan, NX Development Corp.) as an Optical Imaging Agent Indicated in Patients with Gliomas|FDA, Available online: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/aminolevulinic-acid-hydrochloride-known-ala-hcl-gleolan-nx-development-corp-optical-imaging-agent."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/14764172.2011.552613","article-title":"0.5% Liposome-encapsulated 5-aminolevulinic acid (ALA) photodynamic therapy for acne treatment","volume":"13","author":"An","year":"2011","journal-title":"J. Cosmet. Laser Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00701-019-03898-1","article-title":"5-ALA fluorescence\u2013guided surgery in pediatric brain tumors\u2014A systematic review","volume":"161","author":"Schwake","year":"2019","journal-title":"Acta Neurochir."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"E297","DOI":"10.1111\/j.1464-410X.2011.10090.x","article-title":"Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in T a\/T1 patients: A randomized two-centre study","volume":"108","author":"Hermann","year":"2011","journal-title":"BJU Int."},{"key":"ref_42","unstructured":"(2022, August 22). A Randomized, Comparative Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients with Non-Invasive Bladder Cancer\u2014Full Text View\u2014ClinicalTrials.Gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00412971."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1359-6446(99)01412-9","article-title":"Photodynamic therapeutics: Basic principles and clinical applications","volume":"4","author":"Sharman","year":"1999","journal-title":"Drug Discov. Today"},{"key":"ref_44","unstructured":"(2022, August 23). Temoporfin|C44H32N4O4\u2014PubChem, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/60751."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1011-1344(01)00267-6","article-title":"State of the art in the delivery of photosensitizers for photodynamic therapy","volume":"66","author":"Konan","year":"2002","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.canlet.2012.09.012","article-title":"Nanophotosensitizers toward advanced photodynamic therapy of Cancer","volume":"334","author":"Lim","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"119827","DOI":"10.1016\/j.biomaterials.2020.119827","article-title":"Advances in nanomaterials for photodynamic therapy applications: Status and challenges","volume":"237","author":"Chen","year":"2020","journal-title":"Biomaterials"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.addr.2008.08.003","article-title":"Nanoparticles in photodynamic therapy: An emerging paradigm","volume":"60","author":"Chatterjee","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1089\/pho.2017.4308","article-title":"Nanoparticles for Advanced Photodynamic Therapy of Cancer","volume":"35","author":"Abrahamse","year":"2017","journal-title":"Photomed. Laser Surg."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review","volume":"65","author":"Maeda","year":"2000","journal-title":"J. Control. Release"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pdpdt.2010.12.001","article-title":"Nanodrug applications in photodynamic therapy","volume":"8","author":"Paszko","year":"2011","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pdpdt.2008.02.001","article-title":"Bio-nanotechnology and photodynamic therapy\u2014State of the art review","volume":"5","author":"Allison","year":"2008","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"102697","DOI":"10.1016\/j.pdpdt.2021.102697","article-title":"Recent advances and trends in nanoparticles based photothermal and photodynamic therapy","volume":"37","author":"Kadkhoda","year":"2022","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_54","first-page":"20","article-title":"Overcoming the obstacles of current photodynamic therapy in tumors using nanoparticles","volume":"8","author":"Lee","year":"2021","journal-title":"Bioact. Mater."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1039\/C2TB00287F","article-title":"Photosensitizer-conjugated polymeric nanoparticles for redox-responsive fluorescence imaging and photodynamic therapy","volume":"1","author":"Kim","year":"2012","journal-title":"J. Mater. Chem. B"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.addr.2003.07.014","article-title":"Liposomes for photodynamic therapy","volume":"56","author":"DeRycke","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_57","first-page":"9","article-title":"Polymeric micelles to deliver photosensitizers for photodynamic therapy","volume":"56","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nbt927","article-title":"The use of nanocrystals in biological detection","volume":"22","author":"Alivisatos","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1002\/anie.200400651","article-title":"Integrated Nanoparticle-Biomolecule Hybrid Systems: Synthesis, Properties, and Applications","volume":"43","author":"Katz","year":"2004","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1533033818791795","DOI":"10.1177\/1533033818791795","article-title":"Photodynamic Therapy for Metastatic Melanoma Treatment: A Review","volume":"17","author":"Naidoo","year":"2018","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"22094","DOI":"10.3390\/ijms160922094","article-title":"Drug Carrier for Photodynamic Cancer Therapy","volume":"16","author":"Debele","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1010428317734691","article-title":"Targeted photodynamic therapy as potential treatment modality for the eradication of colon cancer and colon cancer stem cells","volume":"39","author":"Hodgkinson","year":"2017","journal-title":"Tumor Biol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1166\/jbn.2015.2090","article-title":"Active Targeting of Nano-Photosensitizer Delivery Systems for Photodynamic Therapy of Cancer Stem Cells","volume":"11","author":"Lin","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2010.08.027","article-title":"To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery","volume":"148","author":"Danhier","year":"2010","journal-title":"J. Control. Release"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1039\/c0pp00147c","article-title":"Targeted photodynamic therapy\u2014A promising strategy of tumor treatment","volume":"10","author":"Bugaj","year":"2011","journal-title":"Photochem. Photobiol. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1039\/D0TB00093K","article-title":"Hybrid nanoparticle composites applied to photodynamic therapy: Strategies and applications","volume":"8","author":"Zhang","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"032006","DOI":"10.1088\/2515-7639\/abf7dd","article-title":"Nanophotosensitizers for cancer therapy: A promising technology?","volume":"4","author":"Arini","year":"2021","journal-title":"J. Phys. Mater."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc1566","article-title":"Cancer nanotechnology: Opportunities and challenges","volume":"5","author":"Ferrari","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_70","first-page":"51","article-title":"Nanocarriers as Potential Targeted Drug Delivery for Cancer Therapy","volume":"Volume 1","author":"Singhvi","year":"2020","journal-title":"Nanoscience in Medicine"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"100253","DOI":"10.1016\/j.impact.2020.100253","article-title":"Smart nanocarriers for cancer treatment: Clinical impact and safety","volume":"20","author":"Liao","year":"2020","journal-title":"NanoImpact"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s11095-006-0284-8","article-title":"Nanotechnology: Intelligent Design to Treat Complex Disease","volume":"23","author":"Couvreur","year":"2006","journal-title":"Pharm. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cca.2014.05.004","article-title":"Targeted anticancer therapy: Overexpressed receptors and nanotechnology","volume":"436","author":"Akhtar","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpharm.2006.02.027","article-title":"A folate receptor-targeted liposomal formulation for paclitaxel","volume":"316","author":"Wu","year":"2006","journal-title":"Int. J. Pharm."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.drudis.2020.09.031","article-title":"Recent advances in targeted nanomedicine as promising antitumor therapeutics","volume":"25","author":"Hejmady","year":"2020","journal-title":"Drug Discov. Today"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Chang, M.-H., Pai, C.-L., Chen, Y.-C., Yu, H.-P., Hsu, C.-Y., and Lai, P.-S. (2018). Enhanced Antitumor Effects of Epidermal Growth Factor Receptor Targetable Cetuximab-Conjugated Polymeric Micelles for Photodynamic Therapy. Nanomaterials, 8.","DOI":"10.3390\/nano8020121"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3389\/fphar.2017.00815","article-title":"Transferrin-Modified Nanoparticles for Photodynamic Therapy Enhance the Antitumor Efficacy of Hypocrellin A","volume":"8","author":"Lin","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/smll.201102695","article-title":"Improved Photodynamic Cancer Treatment by Folate-Conjugated Polymeric Micelles in a KB Xenografted Animal Model","volume":"8","author":"Syu","year":"2012","journal-title":"Small"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.lungcan.2017.09.002","article-title":"Nanoparticle targeted folate receptor 1-enhanced photodynamic therapy for lung cancer","volume":"113","author":"Kato","year":"2017","journal-title":"Lung Cancer"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7150\/thno.17099","article-title":"Smart Cu(II)-aptamer complexes based gold nanoplatform for tumor micro-environment triggered programmable intracellular prodrug release, photodynamic treatment and aggregation induced photothermal therapy of hepatocellular carcinoma","volume":"7","author":"Zhang","year":"2017","journal-title":"Theranostics"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.7150\/thno.15088","article-title":"In vivo Biocompatibility, Biodistribution and Therapeutic Efficiency of Titania Coated Upconversion Nanoparticles for Photodynamic Therapy of Solid Oral Cancers","volume":"6","author":"Lucky","year":"2016","journal-title":"Theranostics"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1080\/09205063.2018.1460141","article-title":"A dual-targeting strategy for enhanced drug delivery and synergistic therapy based on thermosensitive nanoparticles","volume":"29","author":"Wang","year":"2018","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijpharm.2016.03.019","article-title":"An efficient dual-loaded multifunctional nanocarrier for combined photothermal and photodynamic therapy based on copper sulfide and chlorin e6","volume":"503","author":"Tan","year":"2016","journal-title":"Int. J. Pharm."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1021\/acs.biomac.7b00780","article-title":"Bis(pyrene)-Doped Cationic Dipeptide Nanoparticles for Two-Photon-Activated Photodynamic Therapy","volume":"18","author":"Sun","year":"2017","journal-title":"Biomacromolecules"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2147\/IJN.S148305","article-title":"EGFR-targeted photodynamic therapy by curcumin-encapsulated chitosan\/TPP nanoparticles","volume":"ume 13","author":"Tsai","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"19483","DOI":"10.1021\/acsami.8b05252","article-title":"Enhanced Photogeneration of Reactive Oxygen Species and Targeted Photothermal Therapy of C6 Glioma Brain Cancer Cells by Folate-Conjugated Gold\u2013Photoactive Polymer Nanoparticles","volume":"10","author":"Rad","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/mabi.201000231","article-title":"Methylene Blue-Conjugated Hydrogel Nanoparticles and Tumor-Cell Targeted Photodynamic Therapy","volume":"11","author":"Hah","year":"2011","journal-title":"Macromol. Biosci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.pdpdt.2017.06.001","article-title":"Chlorin e6 conjugated silica nanoparticles for targeted and effective photodynamic therapy","volume":"19","author":"Bharathiraja","year":"2017","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Montaseri, H., Kruger, C., and Abrahamse, H. (2021). Inorganic Nanoparticles Applied for Active Targeted Photodynamic Therapy of Breast Cancer. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13030296"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"433","DOI":"10.21037\/qims.2018.05.04","article-title":"Recent advances in nanoparticle carriers for photodynamic therapy","volume":"8","author":"Yi","year":"2018","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1021\/cr5004198","article-title":"Nanoparticles in Photodynamic Therapy","volume":"115","author":"Lucky","year":"2015","journal-title":"Chem. Rev."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1039\/c8pp00143j","article-title":"Mesoporous silica nanoparticles in recent photodynamic therapy applications","volume":"17","author":"Bayir","year":"2018","journal-title":"Photochem. Photobiol. Sci."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Er, \u00d6., Colak, S., Ocakoglu, K., Ince, M., Bresol\u00ed-Obach, R., Mora, M., Sagrist\u00e1, M., Yurt, F., and Nonell, S. (2018). Selective Photokilling of Human Pancreatic Cancer Cells Using Cetuximab-Targeted Mesoporous Silica Nanoparticles for Delivery of Zinc Phthalocyanine. Molecules, 23.","DOI":"10.3390\/molecules23112749"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.3390\/molecules20046284","article-title":"Synthesis, Photophysical Characterization, and Photoinduced Antibacterial Activity of Methylene Blue-loaded Amino- and Mannose-Targeted Mesoporous Silica Nanoparticles","volume":"20","author":"Planas","year":"2015","journal-title":"Molecules"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"10671","DOI":"10.1021\/acsami.5b03087","article-title":"Targeted Delivery of 5-Aminolevulinic Acid by Multifunctional Hollow Mesoporous Silica Nanoparticles for Photodynamic Skin Cancer Therapy","volume":"7","author":"Ma","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1039\/c8pp00271a","article-title":"Photosensitiser-gold nanoparticle conjugates for photodynamic therapy of cancer","volume":"17","author":"Calavia","year":"2018","journal-title":"Photochem. Photobiol. Sci."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1039\/D0MD00284D","article-title":"Peptide directed phthalocyanine\u2013gold nanoparticles for selective photodynamic therapy of EGFR overexpressing cancers","volume":"12","author":"Goddard","year":"2020","journal-title":"RSC Med. Chem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"21832","DOI":"10.1021\/am5026243","article-title":"Aptamer-Functionalized Gold Nanoparticles as Photoresponsive Nanoplatform for Co-Drug Delivery","volume":"6","author":"Shiao","year":"2014","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Sundaram, P., and Abrahamse, H. (2020). Phototherapy Combined with Carbon Nanomaterials (1D and 2D) and their Applications in Cancer Therapy. Materials, 13.","DOI":"10.3390\/ma13214830"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11705-018-1750-7","article-title":"Carbon-based materials for photodynamic therapy: A mini-review","volume":"13","author":"Lu","year":"2018","journal-title":"Front. Chem. Sci. Eng."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1039\/C3NR06835H","article-title":"Photodynamic effect of functionalized single-walled carbon nanotubes: A potential sensitizer for photodynamic therapy","volume":"6","author":"Wang","year":"2014","journal-title":"Nanoscale"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2174\/2211738502666140929211831","article-title":"Nanocarbon Materials for Photodynamic Therapy and Photothermal Therapy","volume":"2","author":"Ruan","year":"2014","journal-title":"Pharm. Nanotechnol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.cej.2018.01.081","article-title":"Magnetofluorescent Fe3O4\/carbon quantum dots coated single-walled carbon nanotubes as dual-modal targeted imaging and chemo\/photodynamic\/photothermal triple-modal therapeutic agents","volume":"338","author":"Zhang","year":"2018","journal-title":"Chem. Eng. J."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.2147\/IJN.S45407","article-title":"The application of hyaluronic acid-derivatized carbon nanotubes in hematoporphyrin monomethyl ether-based photodynamic therapy for in vivo and in vitro cancer treatment","volume":"8","author":"Shi","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1166\/jbn.2014.1963","article-title":"Functionalized Fullerenes in Photodynamic Therapy","volume":"10","author":"Huang","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1039\/b711141j","article-title":"Photodynamic therapy with fullerenes","volume":"6","author":"Mroz","year":"2007","journal-title":"Photochem. Photobiol. Sci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1002\/asia.201300039","article-title":"Enhanced Photodynamic Efficiency of an Aptamer-Guided Fullerene Photosensitizer toward Tumor Cells","volume":"8","author":"Liu","year":"2013","journal-title":"Chem. Asian J."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1039\/C8TB01487F","article-title":"An injectable dipeptide\u2013fullerene supramolecular hydrogel for photodynamic antibacterial therapy","volume":"6","author":"Zhang","year":"2018","journal-title":"J. Mater. Chem. B"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jconrel.2016.06.010","article-title":"Fullerene (C 60)-based tumor-targeting nanoparticles with \u201coff-on\u201d state for enhanced treatment of cancer","volume":"235","author":"Shi","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jconrel.2017.04.041","article-title":"Reinforcing nanomedicine using graphene family nanomaterials","volume":"255","author":"Jaleel","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.2147\/IJN.S68600","article-title":"Graphene-based nanovehicles for photodynamic medical therapy","volume":"4","author":"Shi","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"240","DOI":"10.7150\/thno\/v01p0240","article-title":"Folic Acid-conjugated Graphene Oxide loaded with Photosensitizers for Targeting Photodynamic Therapy","volume":"1","author":"Huang","year":"2011","journal-title":"Theranostics"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Mukherjee, S., Liang, L., and Veiseh, O. (2020). Recent Advancements of Magnetic Nanomaterials in Cancer Therapy. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12020147"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"8946","DOI":"10.1039\/C5NR01932J","article-title":"In vivo targeted magnetic resonance imaging and visualized photodynamic therapy in deep-tissue cancers using folic acid-functionalized superparamagnetic-upconversion nanocomposites","volume":"7","author":"Zeng","year":"2015","journal-title":"Nanoscale"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.colsurfb.2016.10.045","article-title":"Novel folic acid conjugated Fe3O4 -ZnO hybrid nanoparticles for targeted photodynamic therapy","volume":"150","author":"Patel","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"15736","DOI":"10.1021\/ja0386905","article-title":"Semiconductor Quantum Dots for Photodynamic Therapy","volume":"125","author":"Samia","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.2147\/IJN.S130799","article-title":"Effects of arginine\u2013glycine\u2013aspartic acid peptide-conjugated quantum dots-induced photodynamic therapy on pancreatic carcinoma in vivo","volume":"ume 12","author":"Li","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1021\/acsami.6b13150","article-title":"Aptamer-Conjugated Graphene Quantum Dots\/Porphyrin Derivative Theranostic Agent for Intracellular Cancer-Related MicroRNA Detection and Fluorescence-Guided Photothermal\/Photodynamic Synergetic Therapy","volume":"9","author":"Cao","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.18632\/oncotarget.27596","article-title":"Review: Organic nanoparticle based active targeting for photodynamic therapy treatment of breast cancer cells","volume":"11","author":"Montaseri","year":"2020","journal-title":"Oncotarget"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/lsm.21101","article-title":"Liposomal nanostructures for photosensitizer delivery","volume":"43","author":"Jin","year":"2011","journal-title":"Lasers Surg. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/7832216","article-title":"GE11 Peptide Conjugated Liposomes for EGFR-Targeted and Chemophotothermal Combined Anticancer Therapy","volume":"2021","author":"Huang","year":"2021","journal-title":"Bioinorg. Chem. Appl."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1039\/C6NR00014B","article-title":"Site-specific conjugation of single domain antibodies to liposomes enhances photosensitizer uptake and photodynamic therapy efficacy","volume":"8","author":"Broekgaarden","year":"2016","journal-title":"Nanoscale"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jmmm.2018.10.020","article-title":"Dual targeted magnetic photosensitive liposomes for photothermal\/photodynamic tumor therapy","volume":"473","author":"Anilkumar","year":"2018","journal-title":"J. Magn. Magn. Mater."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/1011-1344(93)80178-C","article-title":"Liposome-delivered Zn(II)-2,3-naphthalocyanines as potential sensitizers for PDT: Synthesis, photochemical, pharmacokinetic and phototherapeutic studies","volume":"21","author":"Shopova","year":"1993","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/bjc.1990.89","article-title":"Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency","volume":"61","author":"Reddi","year":"1990","journal-title":"Br. J. Cancer"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jphotobiol.2013.11.007","article-title":"Preparation and characterization of mTHPC-loaded solid lipid nanoparticles for photodynamic therapy","volume":"130","author":"Navarro","year":"2014","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Gibot, L., Demazeau, M., Pimienta, V., Mingotaud, A.-F., Vicendo, P., Collin, F., Martins-Froment, N., Dejean, S., Nottelet, B., and Roux, C. (2020). Role of Polymer Micelles in the Delivery of Photodynamic Therapy Agent to Liposomes and Cells. Cancers, 12.","DOI":"10.3390\/cancers12020384"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.pdpdt.2019.02.014","article-title":"Folate-directed zinc (II) phthalocyanine loaded polymeric micelles engineered to generate reactive oxygen species for efficacious photodynamic therapy of cancer","volume":"25","author":"Lamch","year":"2019","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1021\/acs.molpharmaceut.9b01280","article-title":"EGFR-Targeted Nanobody Functionalized Polymeric Micelles Loaded with mTHPC for Selective Photodynamic Therapy","volume":"17","author":"Liu","year":"2020","journal-title":"Mol. Pharm."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"119666","DOI":"10.1016\/j.biomaterials.2019.119666","article-title":"An iRGD-conjugated prodrug micelle with blood-brain-barrier penetrability for anti-glioma therapy","volume":"230","author":"Lu","year":"2019","journal-title":"Biomaterials"},{"key":"ref_131","unstructured":"(2022, October 22). Study Record|Beta ClinicalTrials.Gov, Available online: https:\/\/beta.clinicaltrials.gov\/study\/NCT01673074?distance=50&term=PDT&cond=cancer&rank=2."},{"key":"ref_132","unstructured":"(2022, October 22). Study Record|Beta ClinicalTrials.Gov, Available online: https:\/\/beta.clinicaltrials.gov\/study\/NCT01256424?distance=50&term=PDT&cond=cancer&rank=3%5D."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Kydd, J., Jadia, R., Velpurisiva, P., Gad, A., Paliwal, S., and Rai, P. (2017). Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems. Pharmaceutics, 9.","DOI":"10.3390\/pharmaceutics9040046"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1021\/acs.biomac.5b01474","article-title":"Dual Stimuli-Responsive Vesicular Nanospheres Fabricated by Lipopolymer Hybrids for Tumor-Targeted Photodynamic Therapy","volume":"17","author":"John","year":"2015","journal-title":"Biomacromolecules"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/rpd\/ncs054","article-title":"Natural radioactivity measurements of building materials in Baotou, China","volume":"152","author":"Zhao","year":"2012","journal-title":"Radiat. Prot. Dosim."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/15\/1\/109\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:54:37Z","timestamp":1760147677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/15\/1\/109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,28]]},"references-count":135,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["pharmaceutics15010109"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics15010109","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,28]]}}}